Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2017-06, Vol.12 (6), p.e65-e68
Main Authors: Chen, Kai, Zhou, Fei, Shen, Wenxiang, Jiang, Tao, Wu, Xue, Tong, Xiaoling, Shao, Yang W., Qin, Songbing, Zhou, Caicun
Format: Article
Language:English
Subjects:
Acrylamides
Aniline Compounds
Antineoplastic Agents - therapeutic use
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Drug Resistance, Neoplasm - genetics
ErbB Receptors - genetics
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Mutation
Piperazines - therapeutic use
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723
cites cdi_FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723
container_end_page e68
container_issue 6
container_start_page e65
container_title Journal of thoracic oncology
container_volume 12
creator Chen, Kai
Zhou, Fei
Shen, Wenxiang
Jiang, Tao
Wu, Xue
Tong, Xiaoling
Shao, Yang W.
Qin, Songbing
Zhou, Caicun
description
doi_str_mv 10.1016/j.jtho.2016.12.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861544366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1556086417300102</els_id><sourcerecordid>1861544366</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723</originalsourceid><addsrcrecordid>eNp9kMtu3CAUhq2qVXNpX6CLimU3dgEDxlI3o1EulaZJlWaPMD7WMMUmATxR3ibP0icr7ky77AJxBP_36-grig8EVwQT8XlX7dLWVzTPFaEVpuxVcUo4FyWpJX59nLEU7KQ4i3GHMeOYybfFCZW4rSljp8V44_fg0Lc56WT9FJGf0MXV5R3awNy0FH33CaZktXPPaO1DAKcToOTRyjzONkCP7iDamPRk_jzfRjtCSHayHbLTr5dVv1--enTzY71ZvyveDNpFeH-8z4v7y4v79XW5ub36ul5tSsOokKUQLWd0oBibhg-amhZ6MFIyTmreDJzCYGop5CCarid8IANIw2qNDe66htbnxadD7UPwjzPEpEYbDTinJ_BzVEQKwhmrhchReoia4GMMMKiHYEcdnhXBarGsdmqxrBbLilCVLWfo47F_7kbo_yF_teYAOwSevEsQ4k83P0FQW9AubRUmuUO2rMydDRYY4zIfIjP25YBBdrO3mYjGwqIvmzZJ9d7-b63fjiid1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1861544366</pqid></control><display><type>article</type><title>Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC</title><source>ScienceDirect</source><creator>Chen, Kai ; Zhou, Fei ; Shen, Wenxiang ; Jiang, Tao ; Wu, Xue ; Tong, Xiaoling ; Shao, Yang W. ; Qin, Songbing ; Zhou, Caicun</creator><creatorcontrib>Chen, Kai ; Zhou, Fei ; Shen, Wenxiang ; Jiang, Tao ; Wu, Xue ; Tong, Xiaoling ; Shao, Yang W. ; Qin, Songbing ; Zhou, Caicun</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/j.jtho.2016.12.024</identifier><identifier>PMID: 28093244</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acrylamides ; Aniline Compounds ; Antineoplastic Agents - therapeutic use ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Drug Resistance, Neoplasm - genetics ; ErbB Receptors - genetics ; Humans ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Mutation ; Piperazines - therapeutic use ; Prognosis</subject><ispartof>Journal of thoracic oncology, 2017-06, Vol.12 (6), p.e65-e68</ispartof><rights>2017 International Association for the Study of Lung Cancer</rights><rights>Copyright © 2017 by the International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723</citedby><cites>FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1556086417300102$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28093244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Zhou, Fei</creatorcontrib><creatorcontrib>Shen, Wenxiang</creatorcontrib><creatorcontrib>Jiang, Tao</creatorcontrib><creatorcontrib>Wu, Xue</creatorcontrib><creatorcontrib>Tong, Xiaoling</creatorcontrib><creatorcontrib>Shao, Yang W.</creatorcontrib><creatorcontrib>Qin, Songbing</creatorcontrib><creatorcontrib>Zhou, Caicun</creatorcontrib><title>Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><subject>Acrylamides</subject><subject>Aniline Compounds</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>ErbB Receptors - genetics</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Mutation</subject><subject>Piperazines - therapeutic use</subject><subject>Prognosis</subject><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kMtu3CAUhq2qVXNpX6CLimU3dgEDxlI3o1EulaZJlWaPMD7WMMUmATxR3ibP0icr7ky77AJxBP_36-grig8EVwQT8XlX7dLWVzTPFaEVpuxVcUo4FyWpJX59nLEU7KQ4i3GHMeOYybfFCZW4rSljp8V44_fg0Lc56WT9FJGf0MXV5R3awNy0FH33CaZktXPPaO1DAKcToOTRyjzONkCP7iDamPRk_jzfRjtCSHayHbLTr5dVv1--enTzY71ZvyveDNpFeH-8z4v7y4v79XW5ub36ul5tSsOokKUQLWd0oBibhg-amhZ6MFIyTmreDJzCYGop5CCarid8IANIw2qNDe66htbnxadD7UPwjzPEpEYbDTinJ_BzVEQKwhmrhchReoia4GMMMKiHYEcdnhXBarGsdmqxrBbLilCVLWfo47F_7kbo_yF_teYAOwSevEsQ4k83P0FQW9AubRUmuUO2rMydDRYY4zIfIjP25YBBdrO3mYjGwqIvmzZJ9d7-b63fjiid1g</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Chen, Kai</creator><creator>Zhou, Fei</creator><creator>Shen, Wenxiang</creator><creator>Jiang, Tao</creator><creator>Wu, Xue</creator><creator>Tong, Xiaoling</creator><creator>Shao, Yang W.</creator><creator>Qin, Songbing</creator><creator>Zhou, Caicun</creator><general>Elsevier Inc</general><general>Copyright by the International Association for the Study of Lung Cancer</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201706</creationdate><title>Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC</title><author>Chen, Kai ; Zhou, Fei ; Shen, Wenxiang ; Jiang, Tao ; Wu, Xue ; Tong, Xiaoling ; Shao, Yang W. ; Qin, Songbing ; Zhou, Caicun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acrylamides</topic><topic>Aniline Compounds</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>ErbB Receptors - genetics</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Mutation</topic><topic>Piperazines - therapeutic use</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Zhou, Fei</creatorcontrib><creatorcontrib>Shen, Wenxiang</creatorcontrib><creatorcontrib>Jiang, Tao</creatorcontrib><creatorcontrib>Wu, Xue</creatorcontrib><creatorcontrib>Tong, Xiaoling</creatorcontrib><creatorcontrib>Shao, Yang W.</creatorcontrib><creatorcontrib>Qin, Songbing</creatorcontrib><creatorcontrib>Zhou, Caicun</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Kai</au><au>Zhou, Fei</au><au>Shen, Wenxiang</au><au>Jiang, Tao</au><au>Wu, Xue</au><au>Tong, Xiaoling</au><au>Shao, Yang W.</au><au>Qin, Songbing</au><au>Zhou, Caicun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>12</volume><issue>6</issue><spage>e65</spage><epage>e68</epage><pages>e65-e68</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28093244</pmid><doi>10.1016/j.jtho.2016.12.024</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2017-06, Vol.12 (6), p.e65-e68
issn 1556-0864
1556-1380
language eng
recordid cdi_proquest_miscellaneous_1861544366
source ScienceDirect
subjects Acrylamides
Aniline Compounds
Antineoplastic Agents - therapeutic use
Carcinoma, Non-Small-Cell Lung - drug therapy
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Drug Resistance, Neoplasm - genetics
ErbB Receptors - genetics
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Mutation
Piperazines - therapeutic use
Prognosis
title Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Mutations%20on%20EGFR%20Leu792%20Potentially%20Correlate%20to%20Acquired%20Resistance%20to%20Osimertinib%20in%C2%A0Advanced%20NSCLC&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Chen,%20Kai&rft.date=2017-06&rft.volume=12&rft.issue=6&rft.spage=e65&rft.epage=e68&rft.pages=e65-e68&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/j.jtho.2016.12.024&rft_dat=%3Cproquest_cross%3E1861544366%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4268-669542f200c75fa2c9edec88451357f52efc3868f67bd15f1fe8c43a0c0bb723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1861544366&rft_id=info:pmid/28093244&rfr_iscdi=true